About Myoscience
Myoscience is a Healthcare company based in Redwood City (United States) founded in 2005, and was acquired by Pacira in March 2019. Technology-driven dermatological products are developed and commercialized. Myoscience has raised $147.68 million across 9 funding rounds from investors including Pacira, Accuitive Medical Ventures and De Novo Ventures. The company has 687 employees. Its focus areas include Life Sciences, Pain Management, Medical Devices and Therapeutic Devices. Its competitors include Saluda Medical, Nalu Medical and Biowave; 3 of its 3 listed competitors have raised funding.
Company details
MyoScience engages in development and commercialization of technology driven dermatological products. Company has a Focused Cold Therapy patented technology delivered by the iovera system. The iovera system is FDA cleared in the United States for use in pain management. In Europe and Canada it is approved for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions. Recently, iovera has reached maximum enrollment for two knee pain studies which is a non-systemic, non-narcotic solution to blocking pain for extended period of time.
- Headquarters Redwood City, United States
- Employees 687
- Stage Acquired
- SectorsHealthcare
- Website myoscience.com
- Social LinkedIn Facebook
- Acquired by Pacira (Mar 2019)
Funding Insights of Myoscience
Myoscience has successfully raised a total of $147.68M across 9 strategic funding rounds. The most recent funding activity was a Series F round of $5 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $147.68M
- Total Rounds 9
- Last Round Series F — $5M
- First Round $10.4M
(Jul 2008)
- Investors Count 6
All 9 funding rounds of Myoscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2018 | $5M | Series F | – | – | – |
| Mar 2018 | $30.94M | Series F | – | – | – |
| Oct 2017 | $14M | Series F | – | – | – |
| Sep 2014 | $8.39M | Series E | – | – | – |
| Sep 2013 | $25M | Series E | – | – | |
| Mar 2012 | $33M | Series D | – | Medicis, Valiance Asset Management | |
| Mar 2011 | $18.76M | Series C | – | – | – |
| Aug 2010 | $2.2M | Series B | – | – | – |
| Jul 2008 | $10.4M | Series B | – | – |
7 investors in total: 7 institutional.
Investors in Myoscience
Myoscience has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Pacira, Accuitive Medical Ventures and De Novo Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage US healthcare investments are made by Accuitive Medical Ventures. | amvpartners.com | Duluth, United States | ||
| denovovc.com | ||||
Comprehensive strategic expertise in healthcare is provided by MEDICIS. | 1994 | medicis.de | Munich, Germany | |
Venture capital fund focused on multiple sectors | valiance-am.com | London, United Kingdom | ||
Specializes in wholesale distribution of construction materials, hardware, plumbing, and heating equipment. | 1999 | saratogaventures.com | Campbell River, Canada | |
| nexusmp.com | ||||
Injectable non-opioid products for post-surgical pain control are developed. | 2006 | pacira.com | Parsippany Troy Hills, United States |
Investor details for Myoscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Myoscience
1 people are tracked at Myoscience (1 in leadership); the tracked headcount is 687.
| Name | Role | Group |
|---|---|---|
Clint Carnell | CEO | Leadership |
Complete people profiles for Myoscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Myoscience
4 dated milestones of Myoscience across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Myoscience is founded.
- Funding First funding round of $10.4M.
- Funding Latest funding round, Series F, of $5.0M.
- Exit Acquired by Pacira.
Competitors of Myoscience
Myoscience has 3 listed competitors in our database, 3 of them funded. They include Saluda Medical, Nalu Medical and Biowave.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| saludamedical.com | 2010 | Bloomington, United States | $500M | Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment | ||
| nalumed.com | 2014 | Carlsbad, United States | $230.97M | Developer of a neurostimulation system for managing intractable chronic pain | ||
| biowave.com | 2000 | Norwalk, United States | $2.08M | 15 | Neuromodulation devices are developed for pain therapy management. |
Detailed competitors of Myoscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pain Management
3 companies that operate in the same segment as Myoscience (Pain Management) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of therapeutics for pain relief and inflammatory diseases | 2004 | New York, New York, United States | USD 51 M | USD 4.33 M | 79 | |
GPCR ligand-based therapeutics for cardiovascular diseases and pain are developed. | 2007 | Philadelphia, Pennsylvania, United States | USD 203 M | USD 3.13 M | 35 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Myoscience
Complete news archive for Myoscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Myoscience
Myoscience was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Myoscience is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Myoscience is a funded company, having raised a total of $147.68M across 9 funding rounds to date. The company's 1st funding round was a Series B of $10.4M, raised on Jul 2008.
Myoscience has 687 employees.
MyoScience engages in development and commercialization of technology driven dermatological products. Company has a Focused Cold Therapy patented technology delivered by the iovera system. The iovera system is FDA cleared in the United States for use in pain management. In Europe and Canada it is approved for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions. Recently, iovera has reached maximum enrollment for two knee pain studies which is a non-systemic, non-narcotic solution to blocking pain for extended period of time.
Myoscience's top competitors include Saluda Medical, Nalu Medical and Biowave.
Myoscience has 7 investors. Key investors include Pacira, Accuitive Medical Ventures, De Novo Ventures, MEDICIS, and Saratoga Ventures.
Yes. Myoscience was acquired by Pacira in March 2019.